Evolve Global Valuation

LIFE Etf  CAD 20.45  0.21  1.02%   
At this time, the entity appears to be fairly valued. Evolve Global Healthcare shows a prevailing Real Value of C$20.66 per share. The current price of the entity is C$20.45. Our model computes the value of Evolve Global Healthcare from reviewing the entity fundamentals such as Net Asset of 4 M, last dividend paid of 0.12, and Annual Yield of 0.09 % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
20.45
Please note that Evolve Global's price fluctuation is very steady at this time. Calculation of the real value of Evolve Global Healthcare is based on 3 months time horizon. Increasing Evolve Global's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Evolve Global is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evolve Etf. However, Evolve Global's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  20.45 Real  20.66 Hype  20.43 Naive  21.12
The intrinsic value of Evolve Global's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Evolve Global's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
20.66
Real Value
21.30
Upside
Estimating the potential upside or downside of Evolve Global Healthcare helps investors to forecast how Evolve etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evolve Global more accurately as focusing exclusively on Evolve Global's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
19.9320.3320.74
Details
Hype
Prediction
LowEstimatedHigh
19.7920.4321.07
Details
Potential
Annual Dividend
LowForecastedHigh
1.081.121.16
Details

Evolve Global Total Value Analysis

Evolve Global Healthcare is now estimated to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Evolve Global fundamentals before making investing decisions based on enterprise value of the company

Evolve Global Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Evolve suggests not a very effective usage of assets in December.

Evolve Global Past Distributions to stockholders

About Evolve Global Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Evolve Global Healthcare. In general, an absolute valuation paradigm, as applied to this etf, attempts to find the value of Evolve Global Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Evolve Global's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Evolve Global's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evolve Global. We calculate exposure to Evolve Global's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Evolve Global's related companies.
LIFE seeks to replicate, to the extent reasonably possible before fees and expenses, the performance of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged, or any successor thereto, while mitigating downside risk. EVOLVE GLBL is traded on Toronto Stock Exchange in Canada.

Other Information on Investing in Evolve Etf

Evolve Global financial ratios help investors to determine whether Evolve Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evolve with respect to the benefits of owning Evolve Global security.